From October 11 to 12, 2025, the "2025 Academic Annual Conference of the Urology Branch of the Chinese Medical Association Western Tour and the Urology Committee of the Chongqing Medical Association" was successfully held in Chongqing. The conference aimed to enhance the standardized diagnosis and treatment level of urological tumors in Chongqing, and to promote the deep integration of academic achievements with clinical practice.
The conference was organized by the Chongqing Medical Association, and co-hosted by the Urology Committee of the Chongqing Medical Association and Chongqing People’s Hospital (Chongqing University Affiliated People’s Hospital). It focused on cutting-edge topics in the field of urology and featured a variety of formats, providing a high-quality platform for academic exchange among urologists.
At the conference, authoritative experts in the industry delivered impactful presentations. Professor Xin Zhongcheng from the Andrology Center of Peking University First Hospital focused on technological innovation, sharing the results of the low-intensity pulsed ultrasound (LIPUS) technology independently developed by WanboLi. He demonstrated the potential application of WanboLi’s technology in the urology field and injected new momentum into the promotion of technology implementation and the improvement of clinical diagnostic and therapeutic efficacy.
Professor Xia Shujie from the First People's Hospital of Shanghai Jiao Tong University gave a speech titled "Molecular Mechanisms and Clinical Research of LIPUS in the Treatment of Late-Onset Hypogonadism (LOH)," thoroughly analyzing the molecular mechanisms of LIPUS in the treatment of LOH, supported by clinical research data. His presentation provided cutting-edge theoretical support and practical references for the diagnosis and treatment of this condition.
WBL LIPUS Technology Principles and Therapeutic Effects
The core mechanism of WanboLi LIPUS is the application of low-energy pulsed ultrasound (intensity range 50-350mW/CM²) to the corpus cavernosa of the penis. This activates endogenous stem cells, promotes blood vessel and nerve regeneration, and repairs damaged vascular endothelium and nerve matrix, thereby improving erectile function at the pathological level. Compared to traditional oral medications (such as PDE5 inhibitors), prosthetic implants, or invasive therapies (such as corporal injections), WanboLi LIPUS is a safe, non-invasive treatment option that avoids drug dependency, related side effects, and surgical complications.
Competitive Advantages of WanboLi LIPUS
1.Non-invasive and Safe
No need for drugs or surgery, avoiding liver and kidney burdens and infection risks, especially suitable for patients with chronic diseases (such as diabetes).
2.Comprehensive Treatment Model
A unique "LIPUS + Psychological Counseling + VR" holistic treatment approach, addressing both physiological repair and psychological intervention, resulting in a patient satisfaction increase of over 30%.
3.Clinical Data Support
Based on clinical validation from over 60 medical institutions globally, its efficacy and safety have been endorsed by authoritative institutions such as UCSF (University of California, San Francisco) and Peking University Hospital.
WBL LIPUS
The successful holding of this conference not only brought cutting-edge academic ideas and technological achievements to the urology field in Chongqing but also helped build an academic collaboration bridge between regions. This lays a solid foundation for improving grassroots urology diagnostic and treatment levels and promoting the high-quality development of the discipline in the future.